glimepiride has been researched along with Diabetes Mellitus, Type 1 in 7 studies
glimepiride: structure given in first source
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Eighty rats were studied for all treatment periods with 40 receiving a daily oral gavage dosage of glimepiride and 40 receiving a daily oral gavage dosage of vehicle solution." | 1.29 | Glimepiride-induced prevention of diabetes and autoimmune events in the BB rat: revised. ( Chan, EK; Charles, MA; Cheta, DM; Kunakorn, T; Lim, J, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooperberg, BA | 1 |
| Cryer, PE | 1 |
| Karges, B | 1 |
| Schnur, D | 1 |
| Ellard, S | 1 |
| Kentrup, H | 1 |
| Karges, W | 1 |
| Wudy, SA | 1 |
| Högel, J | 1 |
| Dollinger, B | 1 |
| Mullis, P | 1 |
| Heinze, E | 1 |
| Riddle, MC | 1 |
| Kawashima, S | 1 |
| Kaneto, H | 1 |
| Sakamoto, K | 1 |
| Yasuda, T | 1 |
| Kuroda, A | 1 |
| Shiraiwa, T | 1 |
| Yamamoto, K | 1 |
| Kasami, R | 1 |
| Matsuoka, TA | 1 |
| Yamasaki, Y | 1 |
| Matsuhisa, M | 1 |
| Cheta, DM | 1 |
| Lim, J | 1 |
| Chan, EK | 2 |
| Kunakorn, T | 1 |
| Charles, MA | 2 |
| Pan, J | 1 |
| Yu, E | 1 |
| Chen, J | 1 |
| Schranz, V | 1 |
1 review available for glimepiride and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Timely initiation of basal insulin.
Topics: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Progression; Drug Therapy, Combination | 2004 |
6 other studies available for glimepiride and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Beta-cell-mediated signaling predominates over direct alpha-cell signaling in the regulation of glucagon secretion in humans.
Topics: C-Peptide; Diabetes Mellitus, Type 1; Eating; Epinephrine; Fasting; Fatty Acids, Nonesterified; Fema | 2009 |
Effective treatment of diabetes caused by activating ABCC8/SUR1 mutation with glimepiride.
Topics: Adolescent; Adult; ATP-Binding Cassette Transporters; Diabetes Mellitus, Type 1; Female; Humans; Hyp | 2012 |
Glimepiride treatment and IGF-I in adolescents with type 1 diabetes: a prospective, randomized, double-blind, placebo-controlled study.
Topics: Adolescent; Child; Diabetes Mellitus, Type 1; Humans; Insulin-Like Growth Factor Binding Protein 3; | 2003 |
Acute progression of severe insulin edema accompanied by pericardial and pleural effusion in a patient with type 2 diabetes.
Topics: Administration, Oral; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Progression; Ede | 2008 |
Glimepiride-induced prevention of diabetes and autoimmune events in the BB rat: revised.
Topics: Animals; Autoimmune Diseases; Blood Glucose; Diabetes Mellitus, Type 1; Glycosuria; Hypoglycemic Age | 1995 |
Prevention and cure of type 1 diabetes in the BB rat by islet allotransplantation and glimepiride treatment.
Topics: Animals; Diabetes Mellitus, Type 1; Disease Models, Animal; Immunosuppressive Agents; Islets of Lang | 1995 |